2019: Fitzpatrick Voted For Studying Diseases That Lack Treatments By
The FDA. In December 2019, Fitzpatrick voted for an amendment to a
bill lowering drug prices for Medicare that would, according to
Congressional Quarterly, "require the Health and Human Services
Department to conduct a study to identify diseases or conditions that
lack treatments approved by the Food and Drug Administration and
instances in which development of such treatments could fill unmet
medical needs for serious, life-threatening, or rare diseases and
conditions. The amendment would also require the study to identify
incentives that would lead to the development, approval, and marketing
of such treatments." The vote was on adoption of an amendment. The House
adopted the amendment by a vote of 380-45. [House Vote 678,
12/12/19; Congressional
Quarterly, 12/12/19;
Congressional Actions,
H.Amdt.717;
Congressional Actions, H.R.3]